Alon Ben-Noon co-founder and CEO of NeuroSense Therapeutics, a drug development company focusing on the treatment of ALS and other neurodegenerative diseases. The post Alon Ben Noon appeared first on CadenSee - Let's Talk Medical.
4 years ago 51
